Molecule to Market is proudly sponsored by Bora Pharmaceuticals - The premium CDMO partner

Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 253

    25+ years as pharma-focused PE fund

    Jim Gale

    / Signet Healthcare Partners

    Jim Gale, Founding Partner & Managing Director at Signet Healthcare Partners discusses the importance and impact of private equity.

  • Episode 252

    2025 Unwrapped: Top 5 Episodes

    Raman Sehgal

    / Molecule to Market

    Here is our host, Raman Sehgal’s top 5 Molecule to Market episodes of 2025.

  • Episode 251

    Doctor Entrepreneur who pulled off a $1.4b exit

    Dr Thomas Dobmeyer

    / ekwithree

    Dr Thomas Dobmeyer, ekwithree talks about his medical career, his experience in niche regulatory affairs and investment.

  • Episode 250

    M2M Monitor Special – 2026

    Raman Sehgal

    / Molecule to Market

    M2M’s 250th episode! Our host Raman Sehgal summarises the highlights from the 2025 guest interviews and provides key insights for 2026.

  • Episode 249

    The master building CEO leading Codis

    Nick Fortin

    / Codis

    Nick Fortin, CEO of Codis talks about his leadership in transforming Particle Dynamis into Codis and managing multiple stakeholders.

  • Episode 248

    From R&D to CRO CEO

    Dr Fozia Saleem

    / Magnitude Biosciences

    Dr Fozia Saleem, CEO of Magnitude Biosciences talks about her experience in R&D, fundraising and growing a university spin out post COVID.

  • Episode 247

    M&A Roundtable Q4 2025 – Reflections and Predictions

    Andrew Gigax, Jason Foss, Jennifer Chadwick & Sabina Ouimet-Storrs

    / William Blair, Bora Pharmaceuticals, Jennifer Chadwick Consulting & GHO Capital Partners

    Hear experts talk about their reflections and predictions from Q4 2025 and how it will shape the pharmaceutical and biotechnology ecosystem.

  • Episode 246

    From Pharma to CRO entrepreneur

    Jean-François Brepson

    / PathoQuest

    Jean-François Brepson, CEO at PathoQuest shares his deep experience as a dedicated leader in biotechnology and pharmaceuticals.

  • Episode 245

    The CEO leading Ensera’s evolution

    Jason Anderson

    / Ensera

    Jason Anderson, CEO of Ensera (formerly SteriPack) discusses about the pharmaceutical and biotechnology supply chain.

  • Episode 244

    CPHI 2025 wrap-up

    Raman Sehgal

    / Molecule to Market Host

    Our host Raman Sehgal discusses the themes and vibe of CPHI 2025 in Frankfurt.

  • Load more